Prostate-specific antigen (PSA) was known to be reproducible in blood of men without biopsy of target tissue that has increased levels in prostate cancer, is detectable in the early stages of prostate cancer and was the most reliable biomarker for monitoring prognosis [17,18,19,20]. The gene discussed is KLK3; the disease is prostate carcinoma.